Sunday, February 10, 2019

from 9:00 am to 7:30 pm including networking event

9:00 Welcome


9:09 Keynote

Advances in ultrahigh speed, Swept Source OCT angiography

9:30 Deep Range Imaging

  • Choroidal tumors imaged on Swept Source Optical Coherence Tomography Angiography
  • Swept Source Optical Coherence Tomography and Angiography findings in intraocular tumors and changes after treatment
  • Vitreous imaging in pathologic myopia
  • Multimodal imaging study of myopic maculopathy by SS-OCT and OCTA
  • Early signs of posterior staphylomas
  • Discussion

10:50 Break with Poster Session


11:25 Diabetes and Vascular Disease Free Papers

  • Analysis of relative blood flow speeds in vascular changes of Diabetic Retinopathy using Variable Interscan Time Analysis (VISTA) OCT Angiography
  • Optical Coherence Tomography Angiography vessel density in healthy and diabetic patients in a reference hospital
  • Choroidal indices as predictors of visual outcomes to anti-VEGF treatment in DME patients, using Swept Source OCT
  • Characterizing Intraretinal Microvascular Abnormalities (IRMA) and Retinal Neovascularization with OCT Angiography
  • Discussion

12:20 Lunch Symposium

OCT Imaging and DME Treatment Management (sponsored by Alimera Sciences)


13:30 Inflammatory Disease

  • Swept Source OCT Angiography in Chorio-Retinal inflammatory Diseases
  • Swept Source OCT Angiography and retinal vasculitis
  • Optical Coherence Tomography Angiography of acute-onset Vogt-Koyanagi-Harada disease in a young female
  • Discussion

14:20 Imaging In Glaucoma

  • Role of SSOCT in the diagnosis of myopic glaucoma
  • Probing the floor of the optic nerve head in Glaucoma
  • Vascular characteristics of Open Angle Glaucoma and healthy controls
  • SSOCT structural parameters associated with paracentral visual field loss in glaucoma
  • Evaluation of aqueous outflow pathway structures using OCT and future clinical applications
  • Discussion

15:45 Break


16:15 Widefield Imaging In Glaucoma

  • Diagnosing and understanding the progression of glaucoma using SSOCT widefield scans
  • Usefulness of widefield OCT imaging in glaucoma
  • Swept source OCT for widefield imaging of the optical texture of the retinal nerve fiber layer
  • Discussion

17:15 Artificial Intelligence in Ophthalmology

  • AI in Ophthalmology
  • Applications of Artificial Intelligence with macular OCT imaging
  • The clinical and technical considerations of building a deep learning system
  • AI for glaucoma detection
  • Discussion

18:30 Evening Reception

Monday, February 11, 2019

from 9:00 am to 5:30 pm

8:30 Choroid and Choriocapillaris in Health and Disease

  • Insights into the choriocapillaris in health and disease
  • Visualization of Choriocapillaris and Choroidal Vasculature in Normal Eyes with En Face Swept-Source Optical Coherence Tomography Versus Angiography
  • A pilot study of chorioretinal structural and vascular abnormalities in psychosis
  • OCTA of the choriocapillaris in age related macular degeneration
  • Discussion

9:40 Oculovascular Disease and its Correlates

  • Polypoidal Choroidal Vasculopathy on Swept Source Optical Coherence Tomography Angiography in Latin America
  • Variation in posterior eye wall shape in PCV
  • New insights into MacTel2
  • Swept Source OCT Angiography in non-proliferative and proliferative MacTel type 2
  • Discussion

10:50 Main Poster Session and Coffee


11:30 Miscellaneous Session

  • Classification & Guidelines for Wide Field Imaging: Recommendations from the International Wide Field Imaging Study Group
  • New classification for epiretinal membranes based on SS-OCT and OCT-A findings
  • New generation of anterior segment OCT – OCT angiography and polarization-sensitive OCT
  • Abnormal macular contour associated maculopathy: Role of SS-OCT in diagnosis and understanding the pathogenesis.
  • Discussion

12:40 Lunch


13:30 Choroidal Neovascularization

  • New Insights into Type 3 Neovascularization
  • Longitudinal changes in subclinical neovascularization detected on OCTA
  • Swept source vs spectral domain OCTA in the detection of CNV
  • CNV in a pediatric age group: does SSOCT make a difference?
  • Quantitative OCT-Angiography for neovascular age related macular degeneration: six months follow-up study
  • Discussion

14:55 Clinical Cases

  • Nodular Scleritis associated with a vortex vein ampulla varix: case report
  • Reversible OCT features of Retinal/choroidal Lymphoma infiltrates
  • Wide-field Swept Source Optical Coherence Tomography and Angiography in choroideremia
  • Discussion

15:35 Break


16:05 Diabetes II

  • Structural and Angiographic OCT findings in Diabetic Retinopathy. What have we learned?
  • Quantification of ischemia in widefield Swept Source OCTA
  • Deep capillary plexus microaneurysms and Diabetic Macular Edema
  • SS OCTA has transformed my management of patients with PDR
  • Discussion

17:20 Closing


17:25 End


In accordance with the regulations in force in personal data protection, we inform you that all data provided will be included in a file property of Topcon Medical Systems, established in 111 Bauer Drive, Oakland, NJ 07436, United States with the only purpose of managing your attendance and participation at the conference, for its publication in the necessary documentation which will be edited during or after the preparation of the conference, even for future editions, and/or to manage your hotel reservation, as well as to provide you with information about future editions of the conference, by means of mailing or electronic mail. You may exercise your rights of access, rectification, cancellation and opposition to the treatment of your data, sending a written communication to the address indicated previously, enclosing a photocopy of your ID card or equivalent document. All your personal data will be processed with the maximum confidentiality, according to the Privacy and Security Policy of this company, and with total compliance to the Personal Data Protection Law 15/1999, of 13 December.

Technical Secretariat

5 Penn Plaza 5th Floor
New York, NY 10001

(+34) 93 505 25 03